Bond.az White LogoBond.az Black Logo

#dox

Latest news and interesting information about dox.

2026-05-30 23:30
|
459

Meeting with Ukrainian Minister

Journalist Mubariz Aslanov recounts his meeting with the Ukrainian minister and the hardships of war.

0
2026-05-30 14:32
|
619

Zelensky Imposes New Sanctions, Includes Iranian Citizens

Ukraine's Zelensky approves new sanctions against Russia, including Iranian and Sudanese citizens in the list of 120 targeted individuals and entities.

0
2026-05-29 12:00
|
255

Maddox Jolie-Pitt Changes Surname

Angelina Jolie and Brad Pitt's adopted son Maddox files to change his surname, dropping Pitt and becoming Maddox Chivan Jolie.

0
2026-05-27 07:34
|
703

Supply shock, debt may hurt central bank independence: ex-Fed official

Former Fed official Donald Kohn says supply shocks and rising debt are increasing pressure on central bank independence.

0
2026-05-26 13:01
|
210

Idox CEO David Meaden to retire after takeover

David Meaden retires as Idox CEO following completion of a takeover by Frankel, owned by Long Path Partners.

0
2026-05-24 12:20
|
681

Lam Research SWOT: stock faces cleanroom constraints

Lam Research SWOT analysis: stock faces cleanroom constraints. Detailed look at the company's strong market position and infrastructure challenges.

0
2026-05-24 06:00
|
270

Doximity stock under pressure from AI spending

Doximity stock faces pressure from AI investments and slowing growth. Analysis of May 2026 quarter and FY2027 outlook.

0
2026-05-23 23:32
|
656

JPMorgan Chase SWOT analysis: stock navigates mixed signals

JPMorgan Chase SWOT analysis: stock navigates mixed signals. Latest financial analysis from Bond.az.

0
2026-05-20 17:30
|
434

Israel Moves Toward Snap Election

Israel moves closer to a snap election after initial vote to dissolve parliament. Netanyahu faces corruption trial and low poll numbers.

0
2026-05-20 11:42
|
472

H.C. Wainwright Reiterates Protara Buy Rating

H.C. Wainwright reiterates Buy rating on Protara Therapeutics (TARA) with $27 target. Encouraging results from lymphatic malformation and bladder cancer trials.

0
2026-05-19 07:35
|
503

Amdocs Stock: AI Shift and Telecom Pressures

SWOT analysis of Amdocs (DOX) stock: AI transition, telecom pressures, financials, and future outlook.

0
2026-05-17 10:22
|
810

Bond yield spike risky for unprepared equities

Investors warn that stock markets haven't priced in inflation risk and are vulnerable to bond yield spikes. Analysis of earnings, geopolitics, and market outlook.

0
2026-05-17 10:21
|
662

Trump-backed faith event sparks church-state debate

Trump-backed Rededicate 250 event criticized for promoting Christian nationalism and excluding other religions. Debate over church-state separation intensifies.

0
2026-05-14 09:43
|
608

Needham Cuts Doximity PT on Growth Worries

Needham lowers Doximity price target from $55 to $27 but keeps Buy rating. Stock down 61% in past year. AI investments and analyst downgrades discussed.

0
...